Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Mar 16, 2020, before the open
10-K filed Mar 16, 2020, 76 days after period end · 0001564590-20-011174
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | — | $2.14K | — | — |
| Net Income | -$4.45M | -$8.52M | -$6.24M | -$3.52M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.11 |
| -$0.21 |
| -$0.23 |
| -$4.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.